Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2018 Sep 4;169(5):300-310.
doi: 10.7326/M17-2383. Epub 2018 Aug 7.

Microvascular Outcomes in Patients With Diabetes After Bariatric Surgery Versus Usual Care: A Matched Cohort Study

Rebecca O'Brien  1 , Eric Johnson  2 , Sebastien Haneuse  3 , Karen J Coleman  4 , Patrick J O'Connor  5 , David P Fisher  1 , Stephen Sidney  1 , Andy Bogart  6 , Mary Kay Theis  2 , Jane Anau  2 , Emily B Schroeder  7 , David Arterburn  2
Affiliations
Observational Study

Microvascular Outcomes in Patients With Diabetes After Bariatric Surgery Versus Usual Care: A Matched Cohort Study

Rebecca O'Brien et al. Ann Intern Med. .

Abstract

Background: Bariatric surgery improves glycemic control in patients with type 2 diabetes mellitus (T2DM), but less is known about microvascular outcomes.

Objective: To investigate the relationship between bariatric surgery and incident microvascular complications of T2DM.

Design: Retrospective matched cohort study from 2005 to 2011 with follow-up through September 2015.

Setting: 4 integrated health systems in the United States.

Participants: Patients aged 19 to 79 years with T2DM who had bariatric surgery (n = 4024) were matched on age, sex, body mass index, hemoglobin A1c level, insulin use, diabetes duration, and intensity of health care use up to 3 nonsurgical participants (n = 11 059).

Intervention: Bariatric procedures (76% gastric bypass, 17% sleeve gastrectomy, and 7% adjustable gastric banding) compared with usual care.

Measurements: Adjusted Cox regression analysis investigated time to incident microvascular disease, defined as first occurrence of diabetic retinopathy, neuropathy, or nephropathy.

Results: Median follow-up was 4.3 years for both surgical and nonsurgical patients. Bariatric surgery was associated with significantly lower risk for incident microvascular disease at 5 years (16.9% for surgical vs. 34.7% for nonsurgical patients; adjusted hazard ratio [HR], 0.41 [95% CI, 0.34 to 0.48]). Bariatric surgery was associated with lower cumulative incidence at 5 years of diabetic neuropathy (7.2% for surgical vs. 21.4% for nonsurgical patients; HR, 0.37 [CI, 0.30 to 0.47]), nephropathy (4.9% for surgical vs. 10.0% for nonsurgical patients; HR, 0.41 [CI, 0.29 to 0.58]), and retinopathy (7.2% for surgical vs. 11.2% for nonsurgical patients; HR, 0.55 [CI, 0.42 to 0.73]).

Limitation: Electronic health record databases could misclassify microvascular disease status for some patients.

Conclusion: In this large, multicenter study of adults with T2DM, bariatric surgery was associated with lower overall incidence of microvascular disease (including lower risk for neuropathy, nephropathy, and retinopathy) than usual care.

Primary funding source: National Institute of Diabetes and Digestive and Kidney Diseases.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None of the authors have any conflicts of interest to declare.

Figures

Figure 1.
Figure 1.
Flow diagram for identification of eligible patients who underwent bariatric surgery and had type 2 diabetes without history of microvascular disease
Figure 2
Figure 2
A-H. Kaplan-Meier-derived estimates of the cumulative incidence of microvascular disease (A-D) and time-varying hazard ratio comparing the risk of incident microvascular disease (E-H). Separate estimates for neuropathy (B, F), nephropathy (C, G), and retinopathy (D, H) are shown, as well as a composite estimate for incident microvascular disease due to any of the three (A, E).
Figure 2
Figure 2
A-H. Kaplan-Meier-derived estimates of the cumulative incidence of microvascular disease (A-D) and time-varying hazard ratio comparing the risk of incident microvascular disease (E-H). Separate estimates for neuropathy (B, F), nephropathy (C, G), and retinopathy (D, H) are shown, as well as a composite estimate for incident microvascular disease due to any of the three (A, E).
Figure 2
Figure 2
A-H. Kaplan-Meier-derived estimates of the cumulative incidence of microvascular disease (A-D) and time-varying hazard ratio comparing the risk of incident microvascular disease (E-H). Separate estimates for neuropathy (B, F), nephropathy (C, G), and retinopathy (D, H) are shown, as well as a composite estimate for incident microvascular disease due to any of the three (A, E).
Figure 2
Figure 2
A-H. Kaplan-Meier-derived estimates of the cumulative incidence of microvascular disease (A-D) and time-varying hazard ratio comparing the risk of incident microvascular disease (E-H). Separate estimates for neuropathy (B, F), nephropathy (C, G), and retinopathy (D, H) are shown, as well as a composite estimate for incident microvascular disease due to any of the three (A, E).
Figure 2
Figure 2
A-H. Kaplan-Meier-derived estimates of the cumulative incidence of microvascular disease (A-D) and time-varying hazard ratio comparing the risk of incident microvascular disease (E-H). Separate estimates for neuropathy (B, F), nephropathy (C, G), and retinopathy (D, H) are shown, as well as a composite estimate for incident microvascular disease due to any of the three (A, E).
Figure 2
Figure 2
A-H. Kaplan-Meier-derived estimates of the cumulative incidence of microvascular disease (A-D) and time-varying hazard ratio comparing the risk of incident microvascular disease (E-H). Separate estimates for neuropathy (B, F), nephropathy (C, G), and retinopathy (D, H) are shown, as well as a composite estimate for incident microvascular disease due to any of the three (A, E).
Figure 2
Figure 2
A-H. Kaplan-Meier-derived estimates of the cumulative incidence of microvascular disease (A-D) and time-varying hazard ratio comparing the risk of incident microvascular disease (E-H). Separate estimates for neuropathy (B, F), nephropathy (C, G), and retinopathy (D, H) are shown, as well as a composite estimate for incident microvascular disease due to any of the three (A, E).
Figure 2
Figure 2
A-H. Kaplan-Meier-derived estimates of the cumulative incidence of microvascular disease (A-D) and time-varying hazard ratio comparing the risk of incident microvascular disease (E-H). Separate estimates for neuropathy (B, F), nephropathy (C, G), and retinopathy (D, H) are shown, as well as a composite estimate for incident microvascular disease due to any of the three (A, E).
See this image and copyright information in PMC

Comment in

References

    1. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56 e5. - PubMed
    1. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85. - PubMed
    1. Dixon JB, O’Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23. - PubMed
    1. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med. 2017;376(7):641–51. - PMC - PubMed
    1. Cummings DE, Arterburn DE, Westbrook EO, Kuzma JN, Stewart SD, Chan CP, et al. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia. 2016;59(5):945–53. - PMC - PubMed

Publication types

MeSH terms